Khiron Life Sciences Corp (KHRN) Cotización

Still being talked about as a supplier in Columbia just doing the work. Colombia's President Wants Weed Legalized Despite Senate Opposition: Prohibition Increases 'Profits Of Drug Trafficking, Violence'

I guess you have to go to Benzinga to read the article, the link did not copy

TOAST.

Not yet. This is a challenging time all around. My attitude is I would be holding anyway. I hope there are no shenanigans but it is nice to see a chart :)

sorry to hear. Is it trading again now on yours? Whatever Khiron's current and future looks like (and it certainly looked damn good in LATAM), I am confident that CEO Alvaro is working hard to make this a success. This is my sense anyhow. GL to all us investors.

Unfortunately it seems to be unavailable on my exchange. I am stuck holding and hoping.

Wow it is BUY TIME for me personally. Selling some other stocks then am backing up the truck.
#Khiron

Reverse split imminent. IMO.

Nice. Solid news.

This is great news! They have non dilutive financing with an investment grade bank! A term loan and a revolving line of credit!
https://investors.khiron.ca/investor-information/news-events/press-releases/detail/279/Khiron-closes-additional-loan-with-investment-grade-bank.htm

They have started selling their products and having them covered in Columbia now also! I can not believe their price is so low. Glad the new Columbian parliament clarified what is covered. This favours Khiron’s operations
https://markets.qtrade.ca/news/story?t=iKXJizM-dSY,RBgdWBB-F545YOMB8ZC_jfb-CAiOktHV&article=223474e7161df822#223474e7161df822

Agreed. Am a big Khiron fan but it has always been a long term investment. Down on paper but holding all my shares and adding regularly. Believe in CEO Alvaro and the company’s potential. Strong fit.

This is my top pick at the moment. This is why. They say what they are going to do and then do it. I think this company will have a very bright future as long as they are interested in paying back their investors by sharing the benefits

NHS reimburses the cost of cannabis treatment to the first Zerenia™ Clinics UK patient

https://www.prnewswire.com/news-releases/nhs-reimburses-the-cost-of-cannabis-treatment-to-the-first-zerenia-clinics-uk-patient-301722263.html

https://www.prnewswire.com/news-releases/government-of-colombia-declares-mandatory-insurance-coverage-for-medical-cannabis-products-301714470.html

Yep. Time to back up the truck here. Our time is near.

UP 41 percent ?
Might be some kind of news. https://equity.guru/2023/01/05/khiron-life-sciences-khrn-v-benefits-from-new-colombian-cannabis-law/

https://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=&insttype=Stock&symb=khrnf&x=61&y=15&time=9&startdate=2%2F4%2F2015&enddate=7%2F19%2F2023&freq=1&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=0&maval=9&uf=0&lf=1&lf2=0&lf3=0&type=2&style=320&size=3&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=9

Columbia is doing what America will not
https://twitter.com/senadogovco/status/1602711868530999297?s=21&t=GcmjH14UkZ_RtPy7JT21Gg

Khiron IS located in Columbia South America. They also now own a pharma distribution company in Germany with all of the required permits to sell cannabis by prescription to the people there. They have GMP compliance and I applaud their very good choice to be the vendor of the products instead of the grower. I have always said cannabis is a commodity. It was only expensive because of the premium for being illegal. When it moves to its proper place it will be sold by the bushel not the gram. I am investing in the future. Where pain relief comes from CBD and THC instead of chemicals. I am investing not trading. I see this as my opportunity of a lifetime because the end of prohibition only happens once. Columbia has some of the best growing conditions in the world. Khiron is in multiple SA countries and the new government in Columbia is pro cannabis and expanding regulations. I am very happy here. The only thing that causes me any concern is the lack of investment here because of the bogus American laws that prevent banks and hedge funds to get in to the most lucrative sector I will see in my life. Canopy made me money but this next wave will set me up for life. I see the results of the opening up of Canada. It does not reflect on the balance sheets yet but it will. Very soon. I am not waiting till after the US gets its act together to get on board.

Never give in !



https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149882339

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149629476





.



.

"Yeah, we're go go start up a marijuana company IN COLUMBIA S.A. !!!!!"........

SUCH business accumen !.......LoL

Yes.......The only thing holding it back is limitation on institutional buying.





.

This is a company that is executing in spite of crazy regulations. The only thing holding it back is limitation on institutional buying. Only limited by the boughs schedule1 designation in the US. The instant that is removed this stock will do very well imo. American heavy handedness is being recognized for what it is. I am here, collecting when I can. This and other cos stuck in the same mire. Cannabis offers incredible opportunity for the patient

It's ashame, while it may have been necessary, the two previous UNANNOUNCED placement sale of stock were too much for this stock to overcome. VOLUME has become anemic as investors have become apathetic , a REVERSE SPLIT is necessary and inevitable for survival.

100% agree. Khiron has a golden set-up and I wholeheartedly believe it is the best cannabis investment at this point.

Nope. There will be no need to. This will fly. I am greatful for the early Holiday gift :)

https://www.newswire.ca/news-releases/khiron-begins-sales-in-switzerland-and-expands-its-medical-cannabis-portfolio-in-germany-and-the-united-kingdom-855788651.html

Reverse split coming here eventually. IMO.

That has been my strategy too. My only regret is that I do not have more cash to put into it. It is one of my largest holdings and it is a better company now than it was when I bought it at a much higher price.

Link didn't work for me, HG. Khiron is without question one of the most undervalued stocks out there in the global MJ space. I have been accumulating down for a long time..

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150667784

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150675716




.

Q2 out soon. https://markets.qtrade.ca/stocks/overview?t=iKXJizM-dSY,RBgdWBB-F545YOIE8pSxiH4dqlAJ3zNr&symbol=CA:KHRN&rtl2=0&agreementVer=1&agreementDate=04/04/2017&status=N&sma=0&lang=en#

Colombian elections......Underway ?

.

Agreed. I have been adding regularly to my share count. Khiron are set up beautifully to make it however, very few actually know this yet. Bargain central at these low prices currently.

It is unusual for the share price to be cheaper for retailers than a private offering. Very good opportunity in my opinion. Even with a bit of dilution. It gives them a cushion till the revenues start getting stronger. Averaging in as I can.

KHIRON LIFE SCIENCES ANNOUNCES PRICING AND SIZE OF OVERNIGHT BROKERED OFFERING

Download as PDFJUNE 02, 2022 2:37PM EDT
/NOT FOR ?DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR THE ?DISSEMINATION, DISTRIBUTION, ?RELEASE OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES./

TORONTO, June 2, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) is pleased to announce that it has priced and sized its previously announced underwritten overnight marketed public offering (the "Offering"). Pursuant to the Offering, the Company will issue 26,700,000 units of the Company (each, a "Unit") at a price of C$0.15 per Unit (the "Offering Price") for aggregate gross proceeds of C$4,005,000. Each Unit will consist of one common share of the Company (each, a "Unit Share") and one Common Share purchase warrant of the Company (each, a "Unit Warrant"), with each Unit Warrant being exercisable to acquire one Common Share (each, a "Warrant Share") at an exercise price of C$0.20 for a period of 24 months following the closing date of the Offering.

Here is the investor’s presentation from yesterday Q1 results.
https://seekingalpha.com/article/4515567-khiron-life-sciences-corp-khrnf-ceo-alvaro-torres-on-q1-2022-results-earnings-call-transcript

Colombian elections sig. ?

.

Here is the transcript of the investor presentation for year end 2021. They are focusing on medical cannabis and clinics. I am sad to see Kuida be put on the back burner but the CBD space is so saturated I think it is a very good move.
https://seekingalpha.com/article/4505892-khiron-life-sciences-khrnf-ceo-alvaro-torres-on-q4-2021-results-earnings-call-transcript

Agreed. Exceptional loading & entry point here. Big future for Khiron..I do like Alvaro our CEO and believe he will see his shareholders right moving forward. His father is a successful executive too so that is a healthy dynamic in our favor.

Yuuuup! And it seems to be our little secret I have no idea why there are not more people here.

This is HUGE.

The super-great Khiron Columbian weed co. !
Will ya' LOOK at this company FLY !

.

The super-great Khiron Columbian weed co. !
Will ya' LOOK at this company FLY !

Khiron has made an agreement to put Zerenia clinics in Mexican health centres

https://markets.qtrade.ca/news/story?t=iKXJizM-dSY,RBgdWBB-F545YOAM95G5jvZwZGoQbWAC&article=5a5bd081c3ba9ead#5a5bd081c3ba9ead


in Mexico
03/30/2022 07:15 AM ET
Teleton has 24 Medical Centers (22 rehabilitation centers, 1 autism center and 1 Children's Hospital for Cancer) located across the country, and around 600,000 patients with disability, cancer and autism conditions
The partnership includes:
-- Establishment of Khiron's Zerenia(TM) medical cannabis clinics within
Teleton's network across Mexico

-- Distribution of Khiron's medical cannabis products in Teleton's
pharmacies

-- Training of Teleton's Health Care Practitioners on delivery of medical
cannabis
TORONTO, March 30, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), the global medical cannabis leader expanding throughout Latin America and Europe, has partnered with health care company Teleton to bring access to medical cannabis to more than 24 medical centers across Mexico.
Khiron is a leader in the marketplace with its end-to-end solution focusing on the category of medical cannabis. Khiron has a proprietary, sustainable model of growing, distributing, and prescribing cannabis for a range of health care solutions in its Zerenia (TM) medical cannabis clinics. Leveraging their wholly-owned medical clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and to drive prescriptions and brand loyalty with patients worldwide.
"The establishment of Khiron's Zerenia(TM) medical cannabis clinics in Teleton's medical centers is only the beginning of our go-to-market strategy and medical partnerships in Mexico," says Alvaro Torres, Khiron CEO and Director. "We are focused on delivering the highest quality and best care to patients and ongoing education to doctors and communities at large."
Khiron has also obtained regulatory quotas (authorization to use a control substance under International Conventions) from Mexico's regulatory agency COFEPRIS for importing CBD and THC into the country and is currently securing permits for imports to begin commercial sales in the country. With Mexico's population of nearly 130 million, it is among the top 15 economies worldwide, Khiron's serves more than 11.7 million people who have conditions treatable with medical cannabis.
Arturo Pichardo, Corporate Medical Director of Teleton, adds, "Teleton and Khiron's Zerenia(TM) clinic network complement each other perfectly with our strong patient focus, as we share the same values about our common mission. This partnership is good news for patients with various medical conditions throughout Mexico."
Khiron has also partnered with Mexico's top university Tecnologico de Monterrey to provide medical cannabis training to doctors across the country, based on Khiron's education programs and real-world evidence from its Zerenia(TM) clinics across Latin America.
About Teleton
Fundación Teletón is a non-profit organization that seeks to serve children with disabilities, cancer and autism, offering them comprehensive and quality care that promotes their full development and inclusion in society. In Mexico, it has 22 Rehabilitation Centers, 1 Autism Center and 1 Children's Hospital for Cancer, located across the country, and around 600,000 patients with disability, cancer and autism conditions attending since 1.999. It is part of ORITEL (The International Organization of Telethons), the integrating entity of 12 American countries (including the United States) that nowadays form part of the Telethon Organization which was created with the objective of providing and developing services of habilitation, rehabilitation and inclusion of children and adolescents with disabilities.
About Khiron Life Sciences Corp.
Khiron is a leading global medical cannabis company with core operations in Latin America and Europe. Leveraging wholly-owned medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and focus on creating access to drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in Colombia, Germany, UK, Peru, and Brazil and is positioned to commence sales in Mexico. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.
Visit Khiron online at investors.khiron.ca
Linkedin https://www.linkedin.com/company/khiron-life-sciences-corp/

Me too, it is my largest holding, not much compared tother folks but I am really happy here. Under water but smiling :) they have done everythjng they said they would and the clinics are brilliant.

It is massive but no-one knows (it yet). Loading regularly.

Khiron is partnering with Rappi to distribute their Kuida cbd products everywhere they have locations in LATAM. It is an agreement from 6months and from there potential to expand.
I like it! They do not even have to staff the booths. To me it seems to be an asset light way to reach customers.
https://twitter.com/khironlife/status/1302380365118689281?s=21

Rappi:

https://en.m.wikipedia.org/wiki/Rappi

Ceo explains what is happening now the government is backing cannabis on its medical insurance


https://www.facebook.com/groups/206749766788545/permalink/1085965288866984/

It gets better
:)
https://markets.qtrade.ca/news/story?t=iKXJizM-dSY,RBgdWBB-F545YOAH9Za9g_UIwaRr8uK5&article=1e2d245e1ed9f187#1e2d245e1ed9f187

Dow Jones
(PR) Mandatory Insurance Coverage for Medical Cannabis Now Expands to More than 50 million Colombians
01/04/2022 07:42 AM ET
-- Starting January 1st, 2022, every insurance provider in Colombia, is now
mandated to cover the costs of high and low THC medical cannabis
prescriptions

-- Significantly improves the current insurance coverage process,
simplifying the procedure and reducing approval times for patients to
obtain insurance coverage across the country

-- Colombia has upwards of 6 million potential patients for medical cannabis
products (Source: IMS Quintiles), and more than 97% of the population is
covered with health insurance

-- In 2021, the Company filled almost 52,000 medical cannabis prescriptions
in Colombia, 9 times more than in 2020. Over 60% of the product sales
were covered by insurance under the previous coverage rules
TORONTO, Jan. 4, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt:A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, announces that the Government of Colombia has added high and low THC medical cannabis to its list of mandated covered medications for every insurance provider in the country. This change will continue to cement Khiron's leadership position in the Colombian domestic medical cannabis market, leveraged by the Company's premium brand and its "seed to sale" medical cannabis clinic model.
"In March 2020, Khiron became the 1st licensed producer in Colombia to sell medical cannabis to patients through our wholly-owned clinics. Since then, the Company has continued to experience double-digit monthly growth and has exceeded more than 57,000 prescriptions sold to date, servicing more than 16,000 individual patients in the country and becoming a category leader in the Colombian medical cannabis industry. In December 2020, the Colombian government included medical cannabis as an approved medication for insurance coverage", commented Alvaro Torres, Khiron CEO, and Director.
"Since then, we have worked with insurance companies across the country to include this medication in their administrative systems. In 2021, 60% of our products were sold through agreements with two major insurance providers. Today, all insurance companies are mandated to cover medical cannabis in Colombia, with less paperwork and hassle for patients. Even though the previous rules were more complicated, the insurance coverage made a dramatic difference in our results:
KPI 2020 2021
# of prescribed patients /
Conversion Rate # of total consults 8% 32%
# of returning patients /
Retention Rate # of new + returning patients 33% 60%
Average monthly CAD spent per month per patient
transaction value on medical cannabis CAD 55 CAD 75
Total prescriptions # medical cannabis prescriptions
sold in Colombia sold 5,600 52,000
With the inclusion of medical cannabis in the mandatory health coverage plan ("POS"), we expect these trends to continue to grow further. Starting January 1(st) 2022, any patient in Colombia will be able to get their medical cannabis medication almost free of charge, regardless of the insurance company they are subscribed to. This unprecedented regulatory framework update will create one of the largest insured markets for medical cannabis in the world and help position Khiron as a leading company in this industry worldwide", added Mr. Torres.
About Khiron Life Sciences Corp.
Khiron is a leading vertically integrated international medical cannabis company with core operations in Latin America and Europe. Leveraging wholly-owned medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure to drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in Colombia, Peru, Germany, UK, and Brazil and is positioned to commence sales in Mexico. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.
Visit Khiron online at investors.khiron.ca

I agree with the both of you I'm still holding long, but I'm not adding.

I agree. Khiron has been laying the foundations (among the LATAM region which is in very early stage of the MJ space) and their success is underway. Khiron is also doing business with the UK and I think the first to do so which is massive. We haven't yet seen a spike in PPS but I am highly confident we will in due course. CEP Alvaro is a gentleman and from a family of good standing people (his father is CEO of a power company) - it is not in his DNA to run this OTCM stock like many scammers do. Success will follow and I am adding quite regularly.

https://www.instagram.com/tv/CXTgQMnAy7X/?utm_medium=copy_link